Skip to main content
SpringerLink
Log in

Presentation, pathogenesis, and treatment of migraine

  • Chapter
Migraine: A Neuroinflammatory Disease?

Part of the book series: Progress in Inflammation Research ((PIR))

  • 77 Accesses

Abstract

Migraine is an intermittent headache syndrome whose pattern is generally easily recognized. It is comprised of a combination of signs and symptoms no one of which (other than headache) is absolutely required for diagnosis. Attacks can occur almost daily or very rarely, indicating that the threshold for experiencing an attack may vary from person to person. In an effort to standardize diagnosis, the International Headache Society has devised diagnostic criteria [1]. These have been useful for research purposes but perform less well in the clinical setting. Nonetheless, these criteria are widely accepted and used. They are summarized in Table 1.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 (Suppl 7): 1–96

    Google Scholar 

  2. Goadsby PJ (2000) Headache. In: DA Warrell, TM Cox, JD Firth (eds): Oxford Textbook of Medicine. Oxford Press, Oxford, 343–349

    Google Scholar 

  3. Goadsby PJ, Lambert GA, Lance JW (1982) Differential effects on the internal and external carotid circulation of the monkey evoked by locus coeruleus stimulation. Brain Res 249: 247–254

    Article  PubMed  CAS  Google Scholar 

  4. Drummond PD, Lance JW (1984) Neurovascular disturbances in headache patients. Clin Exp Neurol 20: 93–99

    PubMed  CAS  Google Scholar 

  5. Honkasalo ML, Kaprio J, Winter T et al (1995) Migraine and concomitant symptoms among 8,167 adult twin pairs. Headache 35: 70–78

    Article  PubMed  CAS  Google Scholar 

  6. Peroutka SJ, Wilhoit T, Jones K (1997) Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) Nco1 alleles. Neurology 49: 201–206

    Article  PubMed  CAS  Google Scholar 

  7. Ophoff RA, Terwindt GM, Vergouwe MN et al (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca 2+ channel gene CACNLIA4. Cell 87: 543–552

    Article  PubMed  CAS  Google Scholar 

  8. Nyholt DR, Lea RA, Goadsby PJ et al (1998) Familial typical migraine: linkage to chro-mosome 19p13 and evidence for genetic heterogeneity. Neurology 50: 1428–1432

    Article  PubMed  CAS  Google Scholar 

  9. Hans M, Luvisetto S, Williams ME et al (1999) Functional consequences of mutations in the human alpha 1A calcium channel subunit linked to familial hemiplegic migraine. J Neurosci 19: 1610–1619

    PubMed  CAS  Google Scholar 

  10. Yakhinista VA, Pilyayskii AI, Limansky YP, Bulgakova NV (1996) Modulation of the activity of midbrain central gray substance neurons by calcium channel antagonists in vitro. Neuroscience 70:159–167

    Article  Google Scholar 

  11. Ramadan NM, Halvorson H, Vande-Linde A et al (1989) Low brain magnesium in migraine. Headache 29: 416–419

    Article  PubMed  CAS  Google Scholar 

  12. Aurora SK, Cao Y, Bowyer SM, Welch KMA (1999) The occipital cortex is hyperexcitable in migraine experimental evidence. Headache 39: 469–476

    Article  PubMed  CAS  Google Scholar 

  13. Wray SH, Mijovic-Prelec D, Kosslyn SM (1995) Visual processing in migraineurs. Brain 118: 25–35

    Article  PubMed  Google Scholar 

  14. Wang W, Schoenen J (1998) Interictal potentiation of passive “oddball” auditory event-related potentials in migraine. Cephalalgia 18: 261–265

    Article  PubMed  CAS  Google Scholar 

  15. Wolff HG (1963) Headache and other head pain. Oxford University Press, New York

    Google Scholar 

  16. Moskowitz MA (1991) The visceral organ brain: implications for the pathophysiology of vascular head pain. Neurology 41: 182–186

    Article  PubMed  CAS  Google Scholar 

  17. Moskowitz MA, MacFarlane R (1993) Neurovascular and molecular mechanisms in migraine headaches. Cerebrovasc Brain Metab Rev 5: 159–177

    PubMed  CAS  Google Scholar 

  18. Cutrer FM, Sorensen AG, Weisskoff RM et al (1998) Perfusion-weighted imaging defects during spontaneous migraine aura. Ann Neurol 43: 25–31

    Article  PubMed  CAS  Google Scholar 

  19. Lashley KS (1941) Patterns of cerebral integration indicated by the scotomas of migraine. Arch Neurol Psychiat 46: 331–339

    Article  Google Scholar 

  20. Milner PM (1958) Note on a possible correspondence between the scotomas of migraine and spreading depression of Ledo. Electroencephalogr Clin Neurophysiol 10: 705

    Article  PubMed  CAS  Google Scholar 

  21. Andersen AR, Friberg L, Olsen TS, Olesen J (1988) SPECT demonstration of delayed hyperemia following hypoperfusion in classic migraine. Arch Neurol 45: 154–159

    Article  PubMed  CAS  Google Scholar 

  22. Lauritzen M, Olesen J (1984) Regional cerebral blood flow during migraine attacks by xenon-133 inhalation and emission tomography. Brain 107: 447–461

    Article  PubMed  Google Scholar 

  23. Woods RP, Iacoboni M, Mazziotta JC (1994) Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 331: 1689–1692

    Article  PubMed  CAS  Google Scholar 

  24. Weiller C, May A, Limmroth V et al (1995) Brainstem activation in spontaneous human migraine attacks. Nature Med 7: 658–660

    Google Scholar 

  25. May A, Kaube H, Buchel C et al (1998) Experimental cranial pain elicited by capsaicin: a PET study. Pain 74: 61–66

    Article  PubMed  CAS  Google Scholar 

  26. Cutrer FM, O’Donnell AO, Sanchez del Rio M (2000) Functional neuroimaging: enhanced understanding of migraine pathophysiology. Neurology 55 (Suppl 2): S36–S45

    PubMed  CAS  Google Scholar 

  27. Markowitz S, Saito K, Moskowitz MA (1987) Neurogenically mediated leakage of plasma proteins occurs from blood vessels in dura mater but not brain. J Neurosci 7: 4129–4136

    PubMed  CAS  Google Scholar 

  28. Buzzi MG, Moskowitz MA (1991) Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine. Cephalalgia 11: 165–168

    Article  PubMed  CAS  Google Scholar 

  29. Lassen L, Jacobsen V, Petersen P et al (1998) Human calcitonin gene-related peptide (hCGRP)-induced headache in migraineurs (abstract). Eur J Pharmacol 5 (Suppl 3): S63

    Google Scholar 

  30. Goadsby PJ, Edvinsson L (1994) Human in vivo evidence for trigeminovascular activation in cluster headache: neuropeptide changes and effects of acute attack therapies. Brain 17: 424–434

    Google Scholar 

  31. Kaube H, Keay KA, Hoskin KL et al (1993) Expression of c-fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Brain Res 629: 95–102

    Article  PubMed  CAS  Google Scholar 

  32. Olesen J, Thomsen LL, Iversen H (1994) Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci 15: 149–153

    Article  PubMed  CAS  Google Scholar 

  33. U.S. Headache Consortium (2000) American Academy of Neurology Headache Guidelines at: http://www.aan.com/public/practiceguidelines/headache_gl.htm

    Google Scholar 

  34. Cady RK, Sheftell F, Lipton RB et al (2000) Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther 22: 1035–1048

    Article  PubMed  CAS  Google Scholar 

  35. O’Quinn S, Davis RL, Gutterman D et al (1999) Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine. Cephalalgia 19: 223–231

    Article  PubMed  Google Scholar 

  36. Wood A (2000) Drugs in pregnancy. New Engl J Med 338: 1130–1137

    Google Scholar 

  37. Shuhaiber S, Pastuszak A, Schick B et al (1998) Pregnancy outcome following first trimester exposure to sumatriptan. Neurology 51: 581–583

    Article  PubMed  CAS  Google Scholar 

  38. Scharff L, Marcus DA, Tuck DC (1996) Maintenance of effects in the nonmedical treatment of headaches during pregnancy. Headache 36: 285–290

    Article  PubMed  CAS  Google Scholar 

  39. Silberstein SD, Massiou H, LeJeunne C et al (2000) Rizatriptan in the treatment of menstrual migraine. Obstetrics Gynecol 96: 237–242

    Article  CAS  Google Scholar 

  40. Loder E, Silberstein S (1998) Clinical efficacy of 2.5 and 5 mg zolmitriptan in migraine associated with menses or in patients using non-progestogen oral contraceptives (abstract). Neurology 50 (Suppl 4): A341

    Google Scholar 

  41. Salonen R, Saiers J (1999) Sumatriptan is effective in the treatment of menstrual migraine: a review of prospective studies and retrospective analyses. Cephalalgia 19: 16–19.

    Article  PubMed  CAS  Google Scholar 

  42. Massiou H, Pitei D, Poole PH, Sikes C (2000) Efficacy of eletriptan for the treatment of migraine in women with menstrually associated migraine, and in women on contraceptives or hormone replacement therapy: meta-analyses of randomized clinical trials (abstract). Cephalalgia 20: 435

    Article  Google Scholar 

  43. Silberstein SD, Armellino JJ, Hoffman HD et al (1999) Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies. Clin Ther 21: 475–491

    Article  PubMed  CAS  Google Scholar 

  44. Szekely B, Merryman S, Croft H et al (1989) Prophylactic effects of naproxen sodium on perimenstrual headache: a double blind placebo controlled study. Cephalalgia 9 (Suppl 10): 452–453

    Google Scholar 

  45. Sances G, Martignoni E, Fioroni L et al (1990) Naproxen sodium in menstrual migraine prophylaxis: a double-blind, placebo controlled study. Headache 30: 705–709

    Article  PubMed  CAS  Google Scholar 

  46. Pradalier A, Vincent D, Beaulieu PH et al (1994) Correlation between oestradiol plasma level and therapeutic effect on menstrual migraine. In: FC Rose (ed): New advances in headache research. Smith-Gordon, London, 129–132

    Google Scholar 

  47. Pfaffenrath V (1993) Efficacy and safety of percutaneous estradiol vs. placebo in menstrual migraine (abstract). Cephalalgia 13: 168

    Google Scholar 

  48. Herzog AG (1997) Continuous bromocriptine therapy in menstrual migraine. Neurology 48: 101–102

    Article  PubMed  CAS  Google Scholar 

  49. O’Dea PK, Davis EH (1990) Tamoxifen in the treatment of menstrual migraine. Neurology 40: 1470–1471

    Article  PubMed  Google Scholar 

  50. Powles TJ (1986) Prevention of migraineous headaches by tamoxifen. Lancet 2: 1344.

    Article  PubMed  CAS  Google Scholar 

  51. Silberstein SD, Merriam GR (1993) Sex hormones and headache. J Pain Symptom Management 8: 98–114

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Spaulding Rehabilitation Hospital, Pain Inpatient Unit, 125 Nashua Street, Boston, MA, 02114-1198, USA

    Elizabeth W. Loder

Authors
  1. Elizabeth W. Loder
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Brigham and Women’s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA

    Egilius L. H. Spierings

  2. Headache Unit, Department of Neurology, FundaciĂłn Hospital AlcorcĂłn Juan Carlos I University, Madrid, Spain

    Margarita Sánchez del Río

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Basel AG

About this chapter

Cite this chapter

Loder, E.W. (2002). Presentation, pathogenesis, and treatment of migraine. In: Spierings, E.L.H., Sánchez del Río, M. (eds) Migraine: A Neuroinflammatory Disease?. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8131-9_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-8131-9_3

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-9449-4

  • Online ISBN: 978-3-0348-8131-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation